To further verify that both FGFR1 and FGF2 are required for cell survival against ALK-TKIs, we established FGFR1- and FGF2-overexpressing SNU2535 cells with ALK + NSCLC. The gene discussed is FGF2; the disease is non-small cell lung carcinoma.